The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Grigorian O.R.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia Rossii, Moskva

Andreeva E.N.

Mediko-geneticheskoe otdelenie Moskovskogo oblastnogo NII akusherstva i ginekologii

The alternative and additional methods of therapy in climacteric patients with menopause and diabetes mellitus type 1 and 2

Authors:

Grigorian O.R., Andreeva E.N.

More about the authors

Read: 2163 times


To cite this article:

Grigorian OR, Andreeva EN. The alternative and additional methods of therapy in climacteric patients with menopause and diabetes mellitus type 1 and 2. Russian Journal of Human Reproduction. 2013;(1):87‑90. (In Russ.)

References:

  1. Aleksandrov A.A. Sakharnyi diabet: bolezn' "vzryvayushchikhsya" blyashek. Consilium Medicum 2001; 1: 10: 2, 4, 6, 7.
  2. Grigoryan O.R., Andreeva E.N. Menopauzal'nyi sindrom u zhenshchin s narusheniyami uglevodnogo obmena. Nauchno-prakticheskoe rukovodstvo (2-e izd., dop.). M 2011; 60-69.
  3. Gromova O.A., Torshin I.Yu., Limanova O.A., Nikonov A.A. Patofiziologiya vegetativno-sosudistykh paroksizmov (prilivy) u zhenshchin v period menopauzy i mekhanizm deistviya Β-alanina. Novaya kliniko-farmakologicheskaya kontseptsiya. Ginekologiya 2010; 2: 29-36.
  4. Zarochentseva N.V., Dzhidzhikhiya L.K. Vozmozhnosti primeneniya klimalanina pri vazomotornykh paroksizmakh u zhenshchin v klimaktericheskom periode. Ros vestn akush-gin 2012; 12: 3: 92-96.
  5. Programma zdorov'ya dlya zhenshchin starshe 35 let. Prakticheskoe rukovodstvo. M 2007; 215-220.
  6. Rukovodstvo po klimakteriyu. Pod red. V.P. Smetnik, V.I. Kulakova. M 2001; 39-57.
  7. Smetnik V.P. Obosnovanie i printsipy zamestitel'noi gormonoterapii v klimakterii. Probl reprod 1996; 3: 32-37.
  8. Smetnik V.P. Selektivnye estrogen-retseptornye modulyatory - al'ternativa zamestitel'noi gormonoterapii. Rukovodstvo po osteoporozu. Pod red. L.I. Benevolenskoi. M: Binom 2003; 236-244.
  9. Smetnik V.P., Shestakova I.G. Sovremennye predstavleniya o menopauzal'nom metabolicheskom sindrome. Consilium Medicum 2003; 5: 9: 543-546.
  10. Smetnik V.P. Al'ternativa zamestitel'noi gormonoterapii. Meditsina klimakteriya. M: Litera 2006; 166-186.
  11. Smetnik V.P., Karelina S.N. Al'ternativnye puti korrektsii klimaktericheskikh rasstroistv. Klimakterii 2004; 4: 3-6.
  12. Yureneva S.V., Moiseev S.V. Negormonal'nye metody lecheniya vazomotornykh simptomov. Klin farmakol i terap 2010; 2: 69-74.
  13. Abraira S., Colwell J., Nutall F. et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Arch Intern Med 1997; 157: 181-188.
  14. Barrett-Connor E., Laakso M. Ishemic heart disease risk in postmenopausal women. Effect of estrogen use on glucose and insulin level. Arteriosclerosis 1990; 10: 4: 531-534.
  15. Brussaard H.E., Gevers Leuven J.A., Fr Eolich M. et al. Short-term oestrogen replacement therapy improver insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 1997; 40: 7: 843-849.
  16. Eaker E.D., Chesebro J.H., Sacks P.M. et al. Cardiovascular disease in women. Circulation 1993; 88: 4: 1999-2009.
  17. Haffner S.M., Valdez R.A., Hazuda H.P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 6: 715-722.
  18. Jovanovic-Peterson L. Hormone replacement therapy and diabetes. Clin Diabet 1996; 142: 146-151.
  19. Kafonek S.D. Postmenopausal hormone replasement therapy and cardiovascular risk reduction (a review). Drugs 1994; 47: 16-24.
  20. Laakso M. Dyslipidemia, morbidity, and mortality in non-insulin-dependent diabetes mellitus. Lipoproteins and coronary heart disease in non-insulin-dependent diabetes mellitus. J Diabet Complicat 1997; 11: 2: 137-141.
  21. Yasuda M., Kurabayashy T., Yamamoto Y. et al. Effect of hormone replacement therapy on bone and lipid metabolism in women oophorectomized for the treatment of gynecologic malignancies. Int J Gynaecol Obstet 1994; 47: 2: 151-156.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.